GemPharmatech Co., Ltd. (SHA:688046)

GemPharmatech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	522.04	701.37	560.17	421.71	293.52	524.2
Short-Term Investments	87.4	109.33	120.1	-	-	-
Trading Asset Securities	670.25	467.34	637.72	791.24	205.8	-
Cash & Short-Term Investments	1,280	1,278	1,318	1,213	499.31	524.2
Cash Growth	-1.75%	-3.03%	8.66%	142.92%	-4.75%	110.53%
Accounts Receivable	415.22	350.81	269.39	185.45	118.57	90.68
Other Receivables	5.39	6.28	6.09	3.63	39.68	0.16
Receivables	420.61	357.09	275.48	189.08	158.25	90.84
Inventory	62.56	54.2	47.09	49.47	30.08	17.32
Prepaid Expenses	-	-	-	-	3.41	-
Other Current Assets	18.89	20.45	16.96	15.51	15.87	14.89
Total Current Assets	1,782	1,710	1,658	1,467	706.93	647.25
Property, Plant & Equipment	656.03	626.28	624.9	375.15	232.78	163.15
Long-Term Investments	206.92	109.05	175.53	306.94	30.08	-
Other Intangible Assets	47.56	49.05	47.34	48.51	49.53	41.2
Long-Term Deferred Tax Assets	39.6	35.98	31.85	17.05	4.81	5.69
Long-Term Deferred Charges	38.74	40.58	36.68	19.29	24.63	23.83
Other Long-Term Assets	27.87	1.94	3.77	19.77	5.66	2.08
Total Assets	2,798	2,573	2,578	2,254	1,054	883.19
Accounts Payable	64.81	72.18	101.86	50.79	61.73	46.31
Accrued Expenses	44.74	57.42	50.94	46.56	39.04	25.35
Short-Term Debt	240.59	88.04	76.16	12.21	5.15	5.02
Current Portion of Leases	11.91	8.82	9.4	2.61	-	-
Current Income Taxes Payable	-	2.84	14.89	4.09	6.44	10.7
Current Unearned Revenue	134.24	138.23	108.42	89.15	75.91	60
Other Current Liabilities	47.47	3.68	4.75	8.66	3.47	2.09
Total Current Liabilities	543.76	371.2	366.41	214.07	191.74	149.47
Long-Term Debt	-	-	-	-	20.03	-
Long-Term Leases	57.32	35.62	36.07	3.05	0.02	-
Long-Term Unearned Revenue	20.49	22.9	41.04	48.99	50.49	70.4
Long-Term Deferred Tax Liabilities	9.01	8.2	9.41	9.9	6.5	6.08
Total Liabilities	630.58	437.92	452.93	276	268.78	225.95
Common Stock	410	410	410	410	360	360
Additional Paid-In Capital	1,251	1,261	1,258	1,254	276.73	273.66
Retained Earnings	513.53	487.61	455.4	313.3	148.63	23.71
Treasury Stock	-14.73	-32.67	-	-	-	-
Comprehensive Income & Other	8.08	8.64	1.09	0.91	0.27	-0.12
Total Common Equity	2,168	2,135	2,125	1,978	785.63	657.24
Shareholders' Equity	2,168	2,135	2,125	1,978	785.63	657.24
Total Liabilities & Equity	2,798	2,573	2,578	2,254	1,054	883.19
Total Debt	309.81	132.48	121.62	17.86	25.2	5.02
Net Cash (Debt)	969.88	1,146	1,196	1,195	474.11	519.18
Net Cash Growth	-15.38%	-4.25%	0.11%	152.07%	-8.68%	122.86%
Net Cash Per Share	2.34	2.82	2.94	3.05	1.33	1.43
Filing Date Shares Outstanding	408.99	407.41	410	410	410	360
Total Common Shares Outstanding	408.99	407.41	410	410	360	360
Working Capital	1,238	1,339	1,291	1,253	515.19	497.78
Book Value Per Share	5.30	5.24	5.18	4.82	2.18	1.83
Tangible Book Value	2,120	2,086	2,077	1,929	736.1	616.05
Tangible Book Value Per Share	5.18	5.12	5.07	4.71	2.04	1.71
Buildings	325.15	324.85	311.67	97.08	97.78	93.13
Machinery	269.01	263.75	229.67	129.2	93.79	69
Construction In Progress	112.27	90.85	89.6	171.67	53.02	2.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.